Evidence map›Paper›PMID 42834112›Full record

ArticleBone marrow transplantation2026

Safety of letermovir-triazole co-administration regarding the risk of invasive fungal infection in allogeneic hematopoietic cell transplantation patients.

Micha Srour, Adeline Dujardin, David Beauvais, Paul Chauvet, Valérie Coiteux, Léonardo Magro, Nicolas Gazeau, Serge Alfandari, Fanny Moreau, Pascal Odou and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Micha SrourCHU Lille, Hematology Department, Lille, France.
Adeline DujardinCHU Lille, Institut de Pharmacie, Lille, F-59000, France.
David BeauvaisCHU Lille, Hematology Department, Lille, France.ORCID http://orcid.org/0000-0003-1866-828X
Paul ChauvetCHU Lille, Hematology Department, Lille, France.ORCID http://orcid.org/0000-0001-6326-9283
Valérie CoiteuxCHU Lille, Hematology Department, Lille, France.
Léonardo MagroCHU Lille, Hematology Department, Lille, France.
Nicolas GazeauCHU Lille, Hematology Department, Lille, France.ORCID http://orcid.org/0000-0003-3449-6676
Serge AlfandariInfectious Disease Department, Gustave Dron Hospital, Tourcoing, France.
Fanny MoreauCHU Lille, Institut de Pharmacie, Lille, F-59000, France.
Pascal OdouCHU Lille, Hematology Department, Lille, France.
Ibrahim Yakoub-AghaCHU Lille, Hematology Department, Lille, France.
Nicolas SimonCHU Lille, Institut de Pharmacie, Lille, F-59000, France. nicolas.simon@univ-lille.fr.ORCID http://orcid.org/0000-0001-5257-440X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42834112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.